Pravastatin Intervention to Delay Hepatocellular Carcinoma Recurrence
Conditions:   Hepatocellular Carcinoma;   Liver Cirrhoses Interventions:   Drug: Pravastatin Pill;   Drug: Placebo Oral Tablet Sponsors:   Cedars-Sinai Medical Center;   National Institutes of Health (NIH) Recruiting - verified July 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 13, 2017 Category: Research Source Type: clinical trials